Jingnan Xue
- Co-authors
- Haitao ZhaoNan ZhangLonghao ZhangChengpei ZhuXiaobo YangYunchao WangZiyu XunShanshan Wang
- Topics
- Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers)Pancreatic and Hepatic Oncology Research (6 papers)Cancer Mechanisms and Therapy (6 papers)
- Journals
- Journal of Clinical OncologyInternational Journal of Radiation Oncology*Biology*PhysicsFrontiers in Immunology
- Partner nations
- China
In The Last Decade
Jingnan Xue
19 papers receiving 151 citations
Peers
Comparison fields: 5 of 23
- Oncology 86
- Surgery 85
- Pathology and Forensic Medicine 50
- Hepatology 49
- Pulmonary and Respiratory Medicine 43
Countries citing papers authored by Jingnan Xue
This map shows the geographic impact of Jingnan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingnan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingnan Xue more than expected).
Fields of papers citing papers by Jingnan Xue
This network shows the impact of papers produced by Jingnan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingnan Xue. The network helps show where Jingnan Xue may publish in the future.
Co-authorship network of co-authors of Jingnan Xue
This figure shows the co-authorship network connecting the top 25 collaborators of Jingnan Xue. A scholar is included among the top collaborators of Jingnan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingnan Xue. Jingnan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 5 | |
| 10 | 14 | |
| 11 | 8 | |
| 12 | 21 | |
| 13 | 26 | |
| 14 | 2 | |
| 15 | 14 | |
| 16 | The efficacy and safety of bevacizumab as a salvage therapy for patients with advanced hepatocellular carcinoma targeting immune tolerance. | 2 |
| 17 | 19 | |
| 18 | 7 | |
| 19 | 3 | |
| 20 | 14 |
About Jingnan Xue
Jingnan Xue is a scholar working on Health Informatics, Hepatology and Oncology, having authored 21 papers that have together received 151 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Hepatology (49 citations), Oncology (86 citations) and Pathology and Forensic Medicine (50 citations). Jingnan Xue has collaborated with scholars based in China. Frequent co-authors include Haitao Zhao, Nan Zhang, Longhao Zhang, Chengpei Zhu, Xiaobo Yang, Yunchao Wang, Ziyu Xun, Shanshan Wang, Xinting Sang and Junyu Long. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.